Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Peter Hovland (NPI 1720047210)

Field	Value
Entity Type	Individual
Organization	Peter Hovland
Address	850 E Harvard Ave
City	Denver
State	CO
ZIP	80210
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 22, 2006

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider is effectively single‑payer by volume: total Medicare revenue is $1.8M and there is no Medicaid billing on file. The absence of any Medicaid claims means payer mix is concentrated in Medicare revenue only, so performance and growth will be sensitive to Medicare utilization and reimbursement trends rather than state Medicaid policy changes. NPI was enumerated 2006-03-22 (~20 years ago), indicating long tenure in the market.

Revenue is heavily concentrated in a small set of intravitreal drug administrations: the top 3 Medicare codes (J0178, J2777, J3490) account for 76.9% of this provider’s Medicare revenue. J0178 alone represents 53.4% of Medicare revenue ($934.2K), J2777 accounts for 14.0% ($245.3K), and J3490 contributes 9.5% ($166.3K), which points to a business model built around high-value ophthalmic drug delivery.

The clinical service mix is consistent with a retina-focused ophthalmology practice: high revenue and claim counts for intravitreal injection drugs (J0178, J2777, J2781) combined with procedure codes for injections (67028) and retinal imaging (92134) indicate routine, repeated office‑based injections plus diagnostic OCT workflows. For example, J0178 shows 1.3K claims and 67028 shows 1.1K claims, while 92134 appears at 1.5K claims, reinforcing an operational model of frequent imaging paired with injection visits.

Competitive standing for the primary revenue driver J0178 is modest: the provider ranks #938 of 3204 nationally (71th percentile; typical, unremarkable volume for this code), so while J0178 is the single largest revenue source for this clinician, their national activity on this drug is typical rather than dominant. Other high-revenue codes follow similar patterns of typical volume (J2777 ranks #1126 of 2039, 44th percentile; J3490 ranks #841 of 2838, 70th percentile), indicating the practice is a steady participant in the market but not an outsized national leader on these drugs.

There are clear service‑line outliers that refine the competitive picture: 92134 (retinal OCT imaging) is described as "notably above typical national volume" and sits in the 94th percentile, suggesting above‑average imaging throughput relative to peers and supporting the inference of a high injection-to-imaging workflow. Conversely, Q5128 (ranibizumab biosimilar) ranks #354 of 373 (5th percentile; typical, unremarkable volume for this code), which indicates minimal use of that biosimilar compared with a small set of national users.

Drug billing patterns suggest a mix of many low‑paid claims and occasional high‑paid, unclassified drug charges: J2777 shows 8.5K claims at $29 avg paid/claim for $245.3K revenue, implying frequent, low‑unit billings, while J3490 has only 94 claims but a $1769 avg paid/claim yielding $166.3K revenue, which points to infrequent but high‑dollar unclassified drug charges. Operationally this implies separate inventory and billing workflows for routine anti‑VEGF administrations versus episodic expensive drug or supply items reported under J3490.

The provider’s tenure and code mix imply an established specialty practice focused on medical retina care: NPI enumerated 2006-03-22 (~20 years ago) combined with dominant revenue from intravitreal therapy (J0178, J2777, J2781) and strong OCT volume (92134) suggests a sustained clinical focus on chronic retinal diseases requiring recurrent injections and monitoring. Given the lack of Medicaid activity, any strategy or competitive assessment should prioritize Medicare patient access, drug utilization choices, and imaging/injection capacity rather than Medicaid network positioning.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,350	$690	$934.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	8,460	$30	$245.3K
J3490	Unclassified drugs	90	$1,770	$166.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	1,080	$120	$129.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,070	$100	$108.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,450	$30	$45K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	430	$100	$40.9K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	110	$220	$23.6K
J7999	Compounded drug, not otherwise classified	300	$80	$22.7K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	60	$110	$6.8K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Peter Hovland — 1 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	60	740	$690	$618.3K
J2777	22	40	8,910	$30	$456.1K
J2781	3	10	470	$120	$79.4K
Q5128	11	10	220	$220	$76.1K
67028	25	80	670	$100	$73.3K
J3490	8	60	50	$290	$23.1K
J7999	13	50	230	$70	$21.5K
92014	84	670	100	$80	$15.2K
92235	34	50	50	$110	$12.2K
99214	5,972	8,160	80	$80	$11.3K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Peter Hovland, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Douglas Holmes	WY	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Brittney Statler	CO	Ophthalmology Physician	$3.7M	$0
Arthur Korotkin	CO	Ophthalmology Physician	$3.7M	$0
Robert Courtney	CO	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Salil Shukla	CO	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
John Purviance	WY	Radiation Oncology Physician	$2.5M	$0
Cary Chisholm	TX	Anatomic Pathology & Clinical Pathology Physician	$2.5M	$24.7K
Murtaza Adam	CO	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Mimi Liu	CO	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
Matthew Asano	CO	Ophthalmology Physician	$2M	$0

Nearby Providers

Other providers in the same ZIP code as Peter Hovland, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Guardian Recovery - Curawest, LLC	CO	Substance Abuse Rehabilitation Facility	$0	$5.9M
Kidscare Therapy Of Colorado, LLC	CO	Home Health Agency	$0	$5.3M
Yousuf Gaffar	CO	Hematology & Oncology Physician	$1.5M	$0
Harvard Park Surgery Center, LLC	CO	Ambulatory Surgical Clinic/Center	$925.7K	$535.2K
James Swinehart	CO	Specialist	$423.6K	$0
Carl Demidovich	CO	Dermatology Physician	$346.8K	$0
Adam Wolff	CO	Neurology Physician	$337.9K	$0
Jason Jacobs	CO	Ophthalmology Physician	$281.7K	$0
Justin Moon	CO	Neurology Physician	$275.9K	$0
George Frey	CO	Orthopaedic Surgery of the Spine Physician	$219.3K	$0

Peter Hovland — Billing Profile & Reimbursement Data

Sign up for Peter Hovland — Billing Profile & Reimbursement Data policy alerts

Peter Hovland — Billing Profile & Reimbursement Data

Sign up for Peter Hovland — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References